Total pelvic exenteration: The Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003)☆
Introduction
Over 50 years ago, pelvic exenteration was first described by Brunschwig and colleagues from the Memorial Hospital in New York [1]. Initially, pelvic exenteration was utilized for the palliative surgical management of advanced and recurrent gynecologic cancers but, over the next 10–15 years, evolved into a curative intervention for advanced and recurrent gynecologic cancers confined to the central pelvis [2], [3]. The extent of the surgical procedure required has been adapted to the site and location of the recurrent or residual disease. Total pelvic exenteration (TPE) entails the en bloc resection of the pelvic viscera in both the anterior and posterior urogenital compartments and is the only available procedure for extensive tumors of the cervix, uterus, vagina, vulva, colon (usually recto-sigmoid), bladder, urethra and occasionally ovary [4], [5], [6].
Currently, the primary role of TPE is for the treatment of cancers of the cervix that recur in the central pelvis following radiation therapy with or without chemotherapy in patients with no evidence of occult metastatic disease outside the pelvis. Although the incidence of advanced stage cervical cancer appears to be declining in many developed countries, it remains a significant problem for women in developing and third world countries [7], [8], [9], [10], [11]. It is a major health care issue in South America (and other developing and third world countries) where it is still the most common cancer in women [9].
There have been numerous reports describing the surgical procedure, technique and the outcome from numerous prestigious institutions around the world [5], [6], [12], [13], [14], [15], [16], [17], [18], [19]. The patient selection criteria, peri-operative preparation and post-operative care have changed significantly over the past two decades. The surgical procedure has evolved from a purely extirpative/exenterative one to an operation that includes a reconstructive phase which has assumed even greater importance in recent years with refinements in urinary diversion, colon sparing surgery, preservation of the anal sphincter and vaginal and pelvic floor reconstruction.
In keeping with other large academic medical centers, we have made significant modifications to our surgical techniques for both the extirpative and the reconstructive phases of the total pelvic exenteration procedure at the Albert Einstein College of Medicine and Montefiore Medical Center over the past 18 years. We have previously published a series of patients where we described the risk factors for poor prognosis at the time of TPE and those patients who might benefit from intra-operative or post-operative brachytherapy [20]. We have also reported on the modifications, complications and sexual function with regard to vaginal reconstruction using the Vertical Rectus Abdominis Myocutaneous (VRAM) flap at the time of TPE [21]. The majority of the alterations and modifications to the surgical procedures at TPE described in this report were initiated and performed by the primary author (GLG).
Section snippets
Materials and methods
After IRB approval (protocol #04-01-011E), there was a systematic review of in-patient and out-patient medical records from all patients who underwent TPE on the gynecologic oncology service at the Albert Einstein College of Medicine/Montefiore Medical Center from January 1987 to December 2003. Pts who underwent an anterior exenteration only or a posterior exenteration only were excluded from this analysis. A database was developed abstracting the predetermined variables of interest from the
Results
Between 1987 and 2003, TPE was performed on 103 patients. We have follow-up information on all the patients in this group. Additional demographic characteristics are shown in Table 1. The mean age was 52.7 years (range 24–81 years). The race and ethnic distribution was as follows: Caucasian (36%), Hispanic White (34%), African American (26%) and Asian–South Island/Pacific (4%). The majority of the patients (95) underwent the procedure for recurrent cervical cancer, 2 for recurrent endometrial
Comment
We have made a number of significant modifications to the TPE procedure over the past 18 years at the Albert Einstein College of Medicine/Montefiore Medical Center. We do not rely on examination under anesthesia, CT scan or MRI reports to determine whether our patients are eligible candidates for TPE. We offer the patient the option of an exploratory laparotomy to determine whether they are eligible or ineligible for the procedure. We generally do not perform palliative TPE and will usually
References (30)
Relative prognostic significance of preoperative and operative findings in pelvic exenteration
Surg. Clin. North Am.
(1969)- et al.
The role of pelvic exenteration in the management of recurrent rectal cancer
Am. J. Surg.
(2003) - et al.
Surgical management of advanced or recurrent endometrial cancer
Surg. Clin. North Am.
(2001) - et al.
Cervical cancer in Latin America
Semin. Oncol.
(2001) - et al.
Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10-year review of the Memorial Sloan–Kettering Cancer Center experience (1972–1981)
Gynecol. Oncol.
(1989) - et al.
Pelvic exenteration: a 15-year experience in a general metropolitan hospital
Am. J. Obstet. Gynecol.
(1984) - et al.
Pelvic exenteration: factors associated with major surgical morbidity
Gynecol. Oncol.
(1989) - et al.
Pelvic exenteration: prognostic significance of regional lymph node metastasis
Gynecol. Oncol.
(1987) - et al.
Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival?
Int. J. Radiat. Oncol. Biol. Phys.
(1997) Bladder substitution after pelvic evisceration
Surg. Clin. North Am.
(1950)
Complications of the ileocolonic continent urinary reservoir (Miami pouch)
Gynecol. Oncol.
A continent colonic urinary reservoir: the Florida pouch
J. Urol.
Palliative exenteration-what, when, and why?
Am. J. Obstet. Gynecol.
Complete excision of pelvic viscera for abdominal carcinoma
Cancer
Cited by (171)
Primary flap closure of perineal defects to avoid empty pelvis syndrome after pelvic exenteration in gynecologic malignancies: An old question to explore a new answer
2024, European Journal of Surgical OncologyThe changing role for extended resections in an era of advanced radiotherapy techniques and novel therapies in gynaecological malignancy
2022, European Journal of Surgical OncologyA modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration
2022, Gynecologic OncologyThe impact of distance to closest negative margin on survival after pelvic exenteration
2022, Gynecologic OncologyExtended pelvic resection for gynecological malignancies: A review of out-of-the-box surgery
2022, Gynecologic Oncology
- ☆
Presented in part at the annual Society of Gynecologic Oncologists Meeting in Miami in March 2005.